Genetic disruption of cortical interneuron development causes region- and GABA cell type-specific deficits, epilepsy, and behavioral dysfunction.

PubWeight™: 2.18‹?› | Rank: Top 2%

🔗 View Article (PMID 12533622)

Published in J Neurosci on January 15, 2003

Authors

Elizabeth M Powell1, Daniel B Campbell, Gregg D Stanwood, Caleb Davis, Jeffrey L Noebels, Pat Levitt

Author Affiliations

1: Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15261, USA. epowell@pitt.edu

Articles citing this

A genetic variant that disrupts MET transcription is associated with autism. Proc Natl Acad Sci U S A (2006) 3.55

Common circuit defect of excitatory-inhibitory balance in mouse models of autism. J Neurodev Disord (2009) 2.61

The requirement of Nkx2-1 in the temporal specification of cortical interneuron subtypes. Neuron (2008) 2.33

Origins of cortical GABAergic neurons in the cynomolgus monkey. Cereb Cortex (2008) 1.98

The genetic and neurobiologic compass points toward common signaling dysfunctions in autism spectrum disorders. J Clin Invest (2009) 1.66

Genetic evidence implicating multiple genes in the MET receptor tyrosine kinase pathway in autism spectrum disorder. Autism Res (2008) 1.61

Quantitative classification of somatostatin-positive neocortical interneurons identifies three interneuron subtypes. Front Neural Circuits (2010) 1.59

Association of genetic variation in the MET proto-oncogene with schizophrenia and general cognitive ability. Am J Psychiatry (2010) 1.58

A triplet repeat expansion genetic mouse model of infantile spasms syndrome, Arx(GCG)10+7, with interneuronopathy, spasms in infancy, persistent seizures, and adult cognitive and behavioral impairment. J Neurosci (2009) 1.48

A GABAergic projection from the zona incerta to cortex promotes cortical neuron development. Science (2015) 1.45

Dlx5 and Dlx6 regulate the development of parvalbumin-expressing cortical interneurons. J Neurosci (2010) 1.36

Kalirin-7 is an essential component of both shaft and spine excitatory synapses in hippocampal interneurons. J Neurosci (2008) 1.33

Genetics and function of neocortical GABAergic interneurons in neurodevelopmental disorders. Neural Plast (2011) 1.29

Netrin-1-alpha3beta1 integrin interactions regulate the migration of interneurons through the cortical marginal zone. Proc Natl Acad Sci U S A (2009) 1.26

Anxiety, memory impairment, and locomotor dysfunction caused by a mutant thyroid hormone receptor alpha1 can be ameliorated by T3 treatment. Genes Dev (2005) 1.26

Neonatal loss of gamma-aminobutyric acid pathway expression after human perinatal brain injury. J Neurosurg (2006) 1.23

Interneurons in the developing human neocortex. Dev Neurobiol (2011) 1.20

Tbr2-positive intermediate (basal) neuronal progenitors safeguard cerebral cortex expansion by controlling amplification of pallial glutamatergic neurons and attraction of subpallial GABAergic interneurons. Genes Dev (2010) 1.16

Convulsing toward the pathophysiology of autism. Brain Dev (2008) 1.15

Selective cortical interneuron and GABA deficits in cyclin D2-null mice. Development (2007) 1.12

Cocaine exposure decreases GABA neuron migration from the ganglionic eminence to the cerebral cortex in embryonic mice. Cereb Cortex (2004) 1.12

Decreased number of interneurons and increased seizures in neuropilin 2 deficient mice: implications for autism and epilepsy. Epilepsia (2008) 1.07

The autism risk genes MET and PLAUR differentially impact cortical development. Autism Res (2010) 1.04

Primate-specific origins and migration of cortical GABAergic neurons. Front Neuroanat (2009) 1.02

Estrogen receptor beta expression in the embryonic brain regulates development of calretinin-immunoreactive GABAergic interneurons. Proc Natl Acad Sci U S A (2006) 1.02

Hepatocyte growth factor (HGF) modulates GABAergic inhibition and seizure susceptibility. Exp Neurol (2009) 1.01

Prenatal polycyclic aromatic hydrocarbon exposure leads to behavioral deficits and downregulation of receptor tyrosine kinase, MET. Toxicol Sci (2010) 1.00

Prefrontal cognitive deficits in mice with altered cerebral cortical GABAergic interneurons. Behav Brain Res (2013) 1.00

Reversal learning and attentional set-shifting in mice. Neuropharmacology (2011) 1.00

Is autism a disease of the cerebellum? An integration of clinical and pre-clinical research. Front Syst Neurosci (2013) 1.00

Production and organization of neocortical interneurons. Front Cell Neurosci (2013) 1.00

Adipokines: a link between obesity and dementia? Lancet Neurol (2014) 0.99

MicroRNAs tune cerebral cortical neurogenesis. Cell Death Differ (2012) 0.99

Epigenetics and Neural developmental disorders: Washington DC, September 18 and 19, 2006. Epigenetics (2007) 0.99

SH2B1beta (SH2-Bbeta) enhances expression of a subset of nerve growth factor-regulated genes important for neuronal differentiation including genes encoding urokinase plasminogen activator receptor and matrix metalloproteinase 3/10. Mol Endocrinol (2007) 0.98

Loss of microRNAs in pyramidal neurons leads to specific changes in inhibitory synaptic transmission in the prefrontal cortex. Mol Cell Neurosci (2012) 0.98

A review of the evidence for the canonical Wnt pathway in autism spectrum disorders. Mol Autism (2012) 0.97

Developmental impact of a familial GABAA receptor epilepsy mutation. Ann Neurol (2008) 0.97

Decreased Serum Hepatocyte Growth Factor (HGF) in Autistic Children with Severe Gastrointestinal Disease. Biomark Insights (2009) 0.96

Prenatal ontogeny as a susceptibility period for cortical GABA neuron disturbances in schizophrenia. Neuroscience (2013) 0.95

Systemic prenatal insults disrupt telencephalon development: implications for potential interventions. Epilepsy Behav (2005) 0.95

Targeted resequencing of a genomic region influencing tameness and aggression reveals multiple signals of positive selection. Heredity (Edinb) (2011) 0.94

Interneurons are necessary for coordinated activity during reversal learning in orbitofrontal cortex. Biol Psychiatry (2014) 0.92

A common susceptibility factor of both autism and epilepsy: functional deficiency of GABA A receptors. J Autism Dev Disord (2013) 0.92

Use of "MGE enhancers" for labeling and selection of embryonic stem cell-derived medial ganglionic eminence (MGE) progenitors and neurons. PLoS One (2013) 0.91

The promise of an interneuron-based cell therapy for epilepsy. Dev Neurobiol (2011) 0.91

Deletion of Dlx1 results in reduced glutamatergic input to hippocampal interneurons. J Neurophysiol (2011) 0.91

Kalirin, a key player in synapse formation, is implicated in human diseases. Neural Plast (2012) 0.90

Plasma biomarkers of depressive symptoms in older adults. Transl Psychiatry (2012) 0.90

Differential effects of BMP signaling on parvalbumin and somatostatin interneuron differentiation. Development (2009) 0.90

Development and specification of GABAergic cortical interneurons. Cell Biosci (2013) 0.89

Genetic disruption of Met signaling impairs GABAergic striatal development and cognition. Neuroscience (2010) 0.89

Optimizing neuronal differentiation from induced pluripotent stem cells to model ASD. Front Cell Neurosci (2014) 0.89

Cortical interneurons from human pluripotent stem cells: prospects for neurological and psychiatric disease. Front Cell Neurosci (2013) 0.87

Endocannabinoids via CB₁ receptors act as neurogenic niche cues during cortical development. Philos Trans R Soc Lond B Biol Sci (2012) 0.87

The role of Robo3 in the development of cortical interneurons. Cereb Cortex (2009) 0.86

Astrocyte-mediated hepatocyte growth factor/scatter factor supplementation restores GABAergic interneurons and corrects reversal learning deficits in mice. J Neurosci (2010) 0.86

Advanced microscopic imaging methods to investigate cortical development and the etiology of mental retardation. Ment Retard Dev Disabil Res Rev (2005) 0.86

Neurochemical characterization of tyrosine hydroxylase-immunoreactive interneurons in the developing rat cerebral cortex. Brain Res (2008) 0.85

REORGANIZATION OF BARREL CIRCUITS LEADS TO THALAMICALLY-EVOKED CORTICAL EPILEPTIFORM ACTIVITY. Thalamus Relat Syst (2005) 0.85

Haploinsufficiency of the E3 ubiquitin ligase C-terminus of heat shock cognate 70 interacting protein (CHIP) produces specific behavioral impairments. PLoS One (2012) 0.85

CACNA1A haploinsufficiency causes cognitive impairment, autism and epileptic encephalopathy with mild cerebellar symptoms. Eur J Hum Genet (2015) 0.84

MET receptor tyrosine kinase as an autism genetic risk factor. Int Rev Neurobiol (2013) 0.84

Predicting novel histopathological microlesions in human epileptic brain through transcriptional clustering. Brain (2014) 0.83

Do structural changes in GABA neurons give rise to the epileptic state? Adv Exp Med Biol (2014) 0.83

Prenatal exposure of ethanol induces increased glutamatergic neuronal differentiation of neural progenitor cells. J Biomed Sci (2010) 0.83

Genetic disruption of the autism spectrum disorder risk gene PLAUR induces GABAA receptor subunit changes. Neuroscience (2010) 0.82

Altered intrinsic properties of neuronal subtypes in malformed epileptogenic cortex. Brain Res (2010) 0.81

Correlation Between Hepatocyte Growth Factor (HGF) and Gamma-Aminobutyric Acid (GABA) Plasma Levels in Autistic Children. Biomark Insights (2013) 0.81

Interplay of environmental signals and progenitor diversity on fate specification of cortical GABAergic neurons. Front Cell Neurosci (2015) 0.81

Versatility of the mouse reversal/set-shifting test: effects of topiramate and sex. Physiol Behav (2012) 0.80

Anterior Cingulate epilepsy: mechanisms and modulation. Front Integr Neurosci (2014) 0.80

Two functional inhibitory circuits are comprised of a heterogeneous population of fast-spiking cortical interneurons. Neuroscience (2014) 0.80

Examining the genetic and neural components of cognitive flexibility using mice. Physiol Behav (2012) 0.80

Fgfr1 inactivation in the mouse telencephalon results in impaired maturation of interneurons expressing parvalbumin. PLoS One (2014) 0.79

Modulation of parvalbumin interneuron number by developmentally transient neocortical vasopressin receptor 1a (V1aR). Neuroscience (2012) 0.79

Recent Advances in the Genetics of Vocal Learning. Comp Cogn Behav Rev (2015) 0.78

Genes and brain malformations associated with abnormal neuron positioning. Mol Brain (2015) 0.78

Synaptic integration of transplanted interneuron progenitor cells into native cortical networks. J Neurophysiol (2016) 0.78

Comparative density of CCK- and PV-GABA cells within the cortex and hippocampus. Front Neuroanat (2015) 0.78

Urokinase-type plasminogen activator promotes dendritic spine recovery and improves neurological outcome following ischemic stroke. J Neurosci (2014) 0.78

DREADD in parvalbumin interneurons of the dentate gyrus modulates anxiety, social interaction and memory extinction. Curr Mol Med (2016) 0.78

Decreased Hepatocyte Growth Factor (HGF) and Gamma Aminobutyric Acid (GABA) in Individuals with Obsessive-Compulsive Disorder (OCD). Biomark Insights (2013) 0.78

Age dependent forebrain structural changes in mice deficient in the autism associated gene Met tyrosine kinase. Neuroimage Clin (2012) 0.78

Increasing proportions of tyrosine hydroxylase-immunoreactive interneurons colocalize with choline acetyltransferase or vasoactive intestinal peptide in the developing rat cerebral cortex. Brain Res (2011) 0.77

Interneuron development and epilepsy: early genetic defects cause long-term consequences in seizures and susceptibility. Epilepsy Curr (2013) 0.77

A surprising METamorphosis: autism genetics finds a common functional variant. Proc Natl Acad Sci U S A (2006) 0.77

Commentary: the prospect of cell-based therapy for epilepsy. Neurotherapeutics (2009) 0.77

Patient heal thyself: modeling and treating neurological disorders using patient-derived stem cells. Exp Biol Med (Maywood) (2013) 0.76

GABAB receptors in maintenance of neocortical circuit function. Exp Neurol (2014) 0.76

Involvement of cortical fast-spiking parvalbumin-positive basket cells in epilepsy. Prog Brain Res (2016) 0.76

Loss of dopamine D2 receptors increases parvalbumin-positive interneurons in the anterior cingulate cortex. ACS Chem Neurosci (2014) 0.76

Trekking through the telencephalon: hepatocyte growth factor-mediated guidance for parvalbumin-expressing interneurons. Epilepsy Curr (2010) 0.75

Cortical Neural Computation by Discrete Results Hypothesis. Front Neural Circuits (2016) 0.75

NKCC1-Deficiency Results in Abnormal Proliferation of Neural Progenitor Cells of the Lateral Ganglionic Eminence. Front Cell Neurosci (2016) 0.75

HCN Channel Modulation of Synaptic Integration in GABAergic Interneurons in Malformed Rat Neocortex. Front Cell Neurosci (2017) 0.75

Spontaneous lung and lymph node metastasis in transgenic breast cancer is independent of the urokinase receptor uPAR. Clin Exp Metastasis (2015) 0.75

Excitatory neurons sculpt GABAergic neuronal connectivity in the C. elegans motor circuit. Development (2017) 0.75

Articles by these authors

Autism spectrum disorders: developmental disconnection syndromes. Curr Opin Neurobiol (2007) 6.96

Aberrant excitatory neuronal activity and compensatory remodeling of inhibitory hippocampal circuits in mouse models of Alzheimer's disease. Neuron (2007) 6.60

Dysfunction in GABA signalling mediates autism-like stereotypies and Rett syndrome phenotypes. Nature (2010) 5.11

Mild overexpression of MeCP2 causes a progressive neurological disorder in mice. Hum Mol Genet (2004) 4.45

Schizophrenia as a disorder of neurodevelopment. Annu Rev Neurosci (2002) 4.36

Mice lacking Dlx1 show subtype-specific loss of interneurons, reduced inhibition and epilepsy. Nat Neurosci (2005) 4.18

A genetic variant that disrupts MET transcription is associated with autism. Proc Natl Acad Sci U S A (2006) 3.55

BK channel beta4 subunit reduces dentate gyrus excitability and protects against temporal lobe seizures. Nat Neurosci (2005) 3.05

Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma. N Engl J Med (2015) 3.00

Amyloid-β/Fyn-induced synaptic, network, and cognitive impairments depend on tau levels in multiple mouse models of Alzheimer's disease. J Neurosci (2011) 2.96

Sensorineural deafness and seizures in mice lacking vesicular glutamate transporter 3. Neuron (2008) 2.96

Exome sequencing of ion channel genes reveals complex profiles confounding personal risk assessment in epilepsy. Cell (2011) 2.93

A transient placental source of serotonin for the fetal forebrain. Nature (2011) 2.71

Serotonin modulates the response of embryonic thalamocortical axons to netrin-1. Nat Neurosci (2007) 2.70

The conundrums of understanding genetic risks for autism spectrum disorders. Nat Neurosci (2011) 2.61

Evaluation, diagnosis, and treatment of gastrointestinal disorders in individuals with ASDs: a consensus report. Pediatrics (2010) 2.45

Prenatal exposure to drugs: effects on brain development and implications for policy and education. Nat Rev Neurosci (2009) 2.33

Molecular evidence for increased expression of genes related to immune and chaperone function in the prefrontal cortex in schizophrenia. Biol Psychiatry (2007) 2.12

Disruption of cerebral cortex MET signaling in autism spectrum disorder. Ann Neurol (2007) 2.02

Mice lacking sodium channel beta1 subunits display defects in neuronal excitability, sodium channel expression, and nodal architecture. J Neurosci (2004) 1.92

Models for epilepsy and epileptogenesis: report from the NIH workshop, Bethesda, Maryland. Epilepsia (2002) 1.91

Suppression of PKR promotes network excitability and enhanced cognition by interferon-γ-mediated disinhibition. Cell (2011) 1.89

How the timing and quality of early experiences influence the development of brain architecture. Child Dev (2010) 1.87

ADPEAF mutations reduce levels of secreted LGI1, a putative tumor suppressor protein linked to epilepsy. Hum Mol Genet (2005) 1.84

Neuronal LRP1 functionally associates with postsynaptic proteins and is required for normal motor function in mice. Mol Cell Biol (2004) 1.81

Masking epilepsy by combining two epilepsy genes. Nat Neurosci (2007) 1.79

Gene expression profiling reveals alterations of specific metabolic pathways in schizophrenia. J Neurosci (2002) 1.79

Early experience modifies the postnatal assembly of autonomic emotional motor circuits in rats. J Neurosci (2005) 1.76

The organization of the transcriptional network in specific neuronal classes. Mol Syst Biol (2009) 1.74

Association and linkage analyses of RGS4 polymorphisms in schizophrenia. Hum Mol Genet (2002) 1.68

Mutations in high-voltage-activated calcium channel genes stimulate low-voltage-activated currents in mouse thalamic relay neurons. J Neurosci (2002) 1.66

The genetic and neurobiologic compass points toward common signaling dysfunctions in autism spectrum disorders. J Clin Invest (2009) 1.66

Critical appraisal of DNA microarrays in psychiatric genomics. Biol Psychiatry (2006) 1.66

Visualization of transmitter release with zinc fluorescence detection at the mouse hippocampal mossy fibre synapse. J Physiol (2005) 1.63

A mouse model for Glut-1 haploinsufficiency. Hum Mol Genet (2006) 1.63

Novel brain expression of ClC-1 chloride channels and enrichment of CLCN1 variants in epilepsy. Neurology (2013) 1.61

Genetic evidence implicating multiple genes in the MET receptor tyrosine kinase pathway in autism spectrum disorder. Autism Res (2008) 1.61

Integration of neuronal clones in the radial cortical columns by EphA and ephrin-A signalling. Nature (2009) 1.59

RGS4-dependent attenuation of M4 autoreceptor function in striatal cholinergic interneurons following dopamine depletion. Nat Neurosci (2006) 1.58

Gastrointestinal dysfunction in autism: parental report, clinical evaluation, and associated factors. Autism Res (2012) 1.55

Tau loss attenuates neuronal network hyperexcitability in mouse and Drosophila genetic models of epilepsy. J Neurosci (2013) 1.54

To share or not to share: a randomized trial of consent for data sharing in genome research. Genet Med (2011) 1.52

Arc regulates spine morphology and maintains network stability in vivo. Proc Natl Acad Sci U S A (2010) 1.51

Genetic testing in the epilepsies--report of the ILAE Genetics Commission. Epilepsia (2010) 1.51

Kv1.1 potassium channel deficiency reveals brain-driven cardiac dysfunction as a candidate mechanism for sudden unexplained death in epilepsy. J Neurosci (2010) 1.51

A noncoding RNA antisense to moesin at 5p14.1 in autism. Sci Transl Med (2012) 1.51

A triplet repeat expansion genetic mouse model of infantile spasms syndrome, Arx(GCG)10+7, with interneuronopathy, spasms in infancy, persistent seizures, and adult cognitive and behavioral impairment. J Neurosci (2009) 1.48

Sodium channel Scn1b null mice exhibit prolonged QT and RR intervals. J Mol Cell Cardiol (2007) 1.46

Selective deficits in the expression of striatal-enriched mRNAs in Huntington's disease. J Neurochem (2006) 1.46

Identification of new epilepsy treatments: issues in preclinical methodology. Epilepsia (2012) 1.45

Dissociation of corticothalamic and thalamocortical axon targeting by an EphA7-mediated mechanism. Neuron (2005) 1.44

Modeling del(17)(p11.2p11.2) and dup(17)(p11.2p11.2) contiguous gene syndromes by chromosome engineering in mice: phenotypic consequences of gene dosage imbalance. Mol Cell Biol (2003) 1.42

Distinct genetic risk based on association of MET in families with co-occurring autism and gastrointestinal conditions. Pediatrics (2009) 1.37

Amygdala gene expression correlates of social behavior in monkeys experiencing maternal separation. J Neurosci (2007) 1.35

Mouse models of human KCNQ2 and KCNQ3 mutations for benign familial neonatal convulsions show seizures and neuronal plasticity without synaptic reorganization. J Physiol (2008) 1.35

Single-neuron RNA-Seq: technical feasibility and reproducibility. Front Genet (2012) 1.32

Amplified behavioral and endocrine responses to forced swim stress in the Wistar-Kyoto rat. Psychoneuroendocrinology (2002) 1.30

Autism-associated promoter variant in MET impacts functional and structural brain networks. Neuron (2012) 1.29

Genetic enhancement of thalamocortical network activity by elevating alpha 1g-mediated low-voltage-activated calcium current induces pure absence epilepsy. J Neurosci (2009) 1.27

Neuronal Elav-like (Hu) proteins regulate RNA splicing and abundance to control glutamate levels and neuronal excitability. Neuron (2012) 1.27

RGS4 is a negative regulator of insulin release from pancreatic beta-cells in vitro and in vivo. Proc Natl Acad Sci U S A (2010) 1.25

Circuit-specific intracortical hyperconnectivity in mice with deletion of the autism-associated Met receptor tyrosine kinase. J Neurosci (2011) 1.22

MeCP2 is critical within HoxB1-derived tissues of mice for normal lifespan. J Neurosci (2011) 1.19

Fetal mechanisms in neurodevelopmental disorders. Pediatr Neurol (2008) 1.18

Association of oxytocin receptor (OXTR) gene variants with multiple phenotype domains of autism spectrum disorder. J Neurodev Disord (2011) 1.17

Dysregulation of the norepinephrine transporter sustains cortical hypodopaminergia and schizophrenia-like behaviors in neuronal rictor null mice. PLoS Biol (2010) 1.16

Cathepsin B but not cathepsins L or S contributes to the pathogenesis of Unverricht-Lundborg progressive myoclonus epilepsy (EPM1). J Neurobiol (2003) 1.15

Preweaning manganese exposure causes hyperactivity, disinhibition, and spatial learning and memory deficits associated with altered dopamine receptor and transporter levels. Synapse (2010) 1.14

Elevated thalamic low-voltage-activated currents precede the onset of absence epilepsy in the SNAP25-deficient mouse mutant coloboma. J Neurosci (2004) 1.13

Dynamic gene and protein expression patterns of the autism-associated met receptor tyrosine kinase in the developing mouse forebrain. J Comp Neurol (2009) 1.13

Curing epilepsy: progress and future directions. Epilepsy Behav (2009) 1.12

Genetic suppression of transgenic APP rescues Hypersynchronous network activity in a mouse model of Alzeimer's disease. J Neurosci (2014) 1.11

Rai1 deficiency in mice causes learning impairment and motor dysfunction, whereas Rai1 heterozygous mice display minimal behavioral phenotypes. Hum Mol Genet (2007) 1.11

Ethnic stratification of the association of RGS4 variants with antipsychotic treatment response in schizophrenia. Biol Psychiatry (2007) 1.10

Three-dimensional high-resolution diffusion tensor imaging and tractography of the developing rabbit brain. Dev Neurosci (2007) 1.10

Combination of diOlistic labeling with retrograde tract tracing and immunohistochemistry. J Neurosci Methods (2009) 1.09

Evidence of cell-nonautonomous changes in dendrite and dendritic spine morphology in the met-signaling-deficient mouse forebrain. J Comp Neurol (2010) 1.09

Exendin-4 decreases amphetamine-induced locomotor activity. Physiol Behav (2012) 1.09

Genetic deletion of Lsamp causes exaggerated behavioral activation in novel environments. Behav Brain Res (2007) 1.07

Regulation of MET by FOXP2, genes implicated in higher cognitive dysfunction and autism risk. J Neurosci (2011) 1.07

Genome-wide high-density SNP linkage search for glioma susceptibility loci: results from the Gliogene Consortium. Cancer Res (2011) 1.05

The autism risk genes MET and PLAUR differentially impact cortical development. Autism Res (2010) 1.04

Anatomical abnormalities in dopaminoceptive regions of the cerebral cortex of dopamine D1 receptor mutant mice. J Comp Neurol (2005) 1.04

Multiple roles of ephrins during the formation of thalamocortical projections: maps and more. J Neurobiol (2004) 1.04

Gene expression profiling with DNA microarrays: advancing our understanding of psychiatric disorders. Neurochem Res (2002) 1.03

Prenatal exposure to cocaine produces unique developmental and long-term adaptive changes in dopamine D1 receptor activity and subcellular distribution. J Neurosci (2007) 1.03

Altered expression of 14-3-3 genes in the prefrontal cortex of subjects with schizophrenia. Neuropsychopharmacology (2005) 1.03

NOVA-dependent regulation of cryptic NMD exons controls synaptic protein levels after seizure. Elife (2013) 1.03

Autism spectrum disorder: interaction of air pollution with the MET receptor tyrosine kinase gene. Epidemiology (2014) 1.02

Drug exposure early in life: functional repercussions of changing neuropharmacology during sensitive periods of brain development. Curr Opin Pharmacol (2004) 1.02

Autism and 15q11-q13 disorders: behavioral, genetic, and pathophysiological issues. Ment Retard Dev Disabil Res Rev (2004) 1.01

The psychologist as an interlocutor in autism spectrum disorder assessment: insights from a study of spontaneous prosody. J Speech Lang Hear Res (2014) 1.01

ADAR1 and ADAR2 expression and editing activity during forebrain development. Dev Neurosci (2009) 1.01

Prenatal cocaine exposure specifically alters spontaneous alternation behavior. Behav Brain Res (2005) 1.01

Genetic analysis of anterior posterior expression gradients in the developing mammalian forebrain. Cereb Cortex (2006) 1.00